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Abstract
Background Observational studies in South Asian populations have suggested an association between vitamin B12 status and
metabolic traits; however, the findings have been inconclusive. Hence, the aim of the present study was to use a genetic approach
to explore the relationship between metabolic traits and vitamin B12 status in a Sri Lankan population and to investigate whether
these relationships were modified by dietary intake.
Methods A total of 109 Sinhalese adults (61 men and 48 women aged 25–50 years) from Colombo City underwent anthropo-
metric and biochemical measurements, dietary intake analysis, and genetic tests. Genetic risk scores (GRS) based on 10 meta-
bolic single nucleotide polymorphisms (SNPs) (metabolic-GRS) and 10 vitamin B12 SNPs (B12-GRS) were constructed.
Results The B12-GRS was significantly associated with serum vitamin B12 (p = 0.008) but not with metabolic traits (p > 0.05),
whereas the metabolic-GRS had no effect on metabolic traits (p > 0.05) and vitamin B12 concentrations (p > 0.05). An interaction
was observed between B12-GRS and protein energy intake (%) on waist circumference (p = 0.002). Interactions were also seen
between the metabolic-GRS and carbohydrate energy intake (%) on waist-to-hip ratio (p = 0.015).
Conclusion Our findings suggest that a genetically lowered vitamin B12 concentration may have an impact on central obesity in
the presence of a dietary influence; however, our study failed to provide evidence for an impact of metabolic-GRS on lowering
B12 concentrations. Given that our study has a small sample size, further large studies are required to confirm our findings.
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SNPs Single nucleotide polymorphisms
MTHFR Methylenetetrahydrofolate reductase
CPS1 Carbamoyl-phosphate synthase 1
CUBN Cubulin
CD320 CD320 molecule
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TCN2 Transcobalamin 2
CLYBL Citrate lyase beta like
FUT2 Fucosyltransferase 2
TCN1 Transcobalamin 1
FUT6 Fucosyltransferase 6
MUT Methylmalonyl-CoA mutase
CAP10 Calpain 10
KCNJ11 Potassium voltage-gated channel
subfamily J member 11
TCF7L2 Transcription factor 7-like 2
FTO Fat mass and obesity-associated
MC4R Melanocortin 4 receptor
BMI Body mass index
SD Standard deviations
WC Waist circumference
WHR Waist-to-hip ratio
Introduction
In recent years, the incidence of obesity in Sri Lanka has
increased markedly [1]. The prevalence of being overweight
or obese in Sri Lankan adults is 34.4% (25.2% and 9.2% in
2005 and 2006, respectively), with an upward trend being
observed [1, 2]. Obesity increases the risk for certain health
conditions, such as insulin resistance, diabetes mellitus, and
hypertension [3]. South Asians have been observed to exhibit
increased visceral fat and waist circumference (WC),
hyperinsulinemia, and insulin resistance; this has been termed
the BSouth Asian phenotype^ [4]. Despite a known genetic
contribution, the increase in obesity has been largely associat-
ed with changes in lifestyle habits [5, 6]. It is imperative that
modifiable risk factors for obesity and associated metabolic
problems are identified, especially if they can be easily
addressed.
Vitamin B12 is a micronutrient that has been identified as a
modifiable risk factor associated with the progression of met-
abolic disorders. In humans, vitamin B12 acts as an essential
coenzyme involved in DNA synthesis and cellular energy
production [7]. Subclinical deficiency of vitamin B12 has been
linked to higher levels of homocysteine; this may have impor-
tant consequences in the progression of chronic diseases, by
inducing oxidative stress and inflammation [8]. Vitamin B12
deficiency has also been linked to many other complications
including an increased risk of obesity [9–11], diabetes
[12–14], and cardiovascular disease [15]. Currently, one study
has investigated the effect of genetically instrumented vitamin
B12 concentrations on body mass index (BMI) in individuals
with European ancestry; however, there were no associations
between the vitamin B12 genetic risk score (GRS) and BMI
[16].
Genetic studies have implicated several gene loci in the
predisposition to vitamin B12 deficiency, but no study has
yet been carried out in the Sri Lankan population [17]. The
mechanisms bywhich obesity and its comorbidities are related
to vitamin B12 deficiency are poorly understood. Hence, we
conducted a gene-based approach to explore the relationship
between metabolic traits and vitamin B12 status in a Sinhalese
cohort and investigated whether these relationships were mod-
ified by dietary intake in the Genetics Of Obesity and Diabetes
(GOOD) study.
Study participants
The GOOD study is a cross-sectional study that was con-
ducted in the city of Colombo, Sri Lanka, between April
and August 2017. Healthy adults between the ages of 25
and 50 years were enrolled into the study. Exclusion
criteria were having a previous history of type 2 diabetes,
cardiovascular disease, or hypertension, having a BMI of
more than 40 kg/m2 or being classed morbidly obese by a
physician, being blood related to other participants in the
study, having any communicable disease, being pregnant
or lactating, taking dietary or vitamin supplements, and
taking medications that affect lipid metabolism or hyper-
tension (Fig. 1).
Anthropometric measures
Body weight was measured to the nearest 100 g using an
electronic scale (Seca 815, Seca GmbH. Co. kg, Germany)
and height was measured to the nearest millimeter using a
stadiometer (Seca 217, Seca GmbH. Co. kg, Germany). The
BMI calculation was based on the body weight (kg) divided
by the square of body height (m).Waist circumference and hip
circumference were measured using a metal tape (Lufkin
W606PM®, Parsippany, NJ, USA). Body fat percentage was
estimated using a handheld bioelectrical impedance analysis
technique (Omron Body Fat Monitor BF306, Omron, Milton
Keynes, UK).
Biochemical analysis
Blood samples (10 ml) were collected by a trained phleboto-
mist in the morning, after a 12-h overnight fast. Fasting serum
insulin and vitamin B12 levels were determined using the
chemiluminescent microparticle immunoassay method on an
Architect i1000 analyzer (Abbott Laboratories, IL, USA).
Fasting plasma glucose concentrations were measured using
the glucose hexokinase method using the Beckman Coulter
AU5800 analyzer (Beckman Coulter®, California, USA).
Glycated hemoglobin (HbA1c) was estimated by high-
performance liquid chromatography using the BioRad D10
HPLC analyzer (BioRad, Hercules, CA, USA).
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Dietary intake analysis
Dietary intakes were assessed using a previously vali-
dated and published [18] interviewer-administered food
frequency questionnaire (FFQ) containing 85 food items.
In brief, participants were asked to estimate the usual
frequency (number of times per day, week, or month/
never) and the portion sizes of various food items. The
recorded data was analyzed with the NutriSurvey 2007
database (EBISpro, Germany) to estimate energy as well
as macro- and micronutrient consumption [19].
BThe Global Physical Activity Questionnaire^
(GPAQ), developed by the World Health Organization
(WHO), was used to measure physical activity [20].
Individuals were classified as vigorously active, when
they both exercised and engaged in demanding work
activities, and moderately active, when the participants
either exercised or carried out heavy physical work. The
remaining study participants were classified into the
sedentary group.
SNP selection and genotyping
We selected 10 metabolic disease-related single nucleotide
polymorphisms (SNPs) (associated with obesity and diabetes)
(fat mass and obesity-associated [FTO], rs9939609 and
rs8050136; melanocortin 4 receptor [MC4R], rs17782313
and rs2229616; transcription factor 7-like 2 [TCF7L2],
rs12255372 and rs7903146; potassium voltage-gated channel
subfamily J member 11 [KCNJ11], rs5219; calpain 10
[CAPN10], rs3792267, rs2975760, and rs5030952) for our
analysis based on previously published candidate gene asso-
ciation and genome-wide association (GWA) studies for met-
abolic disease-related traits [21–29].
The 10 vitamin B12-related SNPs (methylenetetrahydrofo-
late reductase [MTHFR], rs1801133; carbamoyl-phosphate
Fig. 1 Flow chart of the subject recruitment process
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synthase 1 [CPS1], rs1047891; cubulin [CUBN], rs1801222;
CD320 molecule [CD320], rs2336573; transcobalamin 2
[TCN2], rs1131603; citrate lyase beta like [CLYBL],
rs41281112; fucosyltransferase 2 [FUT2], rs602662;
transcobalamin 1 [TCN1], rs34324219; fucosyltransferase 6
[FUT6], rs778805 and methylmalonyl-CoA mutase [MUT],
rs1141321) were chosen on the basis of the recent review
article by Surendran et al. [17].
Blood samples for the measurement of DNA were
transported in dry ice to the UK. Genomic DNAwas extracted
from a 5-ml whole blood sample from each participant and
genotyping was performed at LGC Genomics (http://www.
lgcgroup.com/services/genotyping), which employs the
competitive allele-specific PCR-KASP® assay.
The Hardy-Weinberg equilibrium (HWE) p values were
computed for the following 20 SNPs. The SNP FUT2
rs602662 and calpain 10 (CAP10) rs3792267 deviated from
the HWE; however, these SNPs were not excluded from anal-
ysis. The FUT2 SNP rs602662 previously departed from
HWE in a GWA study conducted in India; the authors ruled
out that the deviation was not due to a genotyping error and
still used this SNP for analysis in their study [30]. In addition,
the KASP™ genotyping technology used in our study has
been independently assessed to be over 99.8% accurate.
Validation of the KASP™ genotyping was conducted at
LGC genomics, where the genotyping results were assessed
by two project managers separately to confirm that the data
was accurate, and this ruled out genotyping artifacts as possi-
ble reasons for deviation from HWE. The reasons for devia-
tion from HWE could be due to population or racial grouping
substructure (subgrouping), non-random mating, linkage dis-
equilibrium (incomplete mixing of different ancestral popula-
tion), or chance findings [31].
Statistical analysis
The SPSS statistical package (version 22; SPSS Inc., Chicago,
IL, USA) was used for the statistical analysis. Allele frequen-
cies were estimated by gene counting (Table 1). The normality
of variable distribution was verified by the Shapiro-Wilk test,
and data not normally distributed were log transformed prior
to analysis.We performed an independent t test to compare the
means of the quantitative variables between men and women.
Comparison of the means between the two groups was ana-
lyzed by the chi-square test for categorical outcomes.
A schematic representation of the study design is presented
in Fig. 2. The unweighted, risk allele GRS method was calcu-
lated for each participant as the sum of risk allele counts across
each SNP which predicted vitamin B12 status or metabolic
disease risk. The B12-GRS was generated from the SNPs in
Table 1 Genotype distribution of vitamin B12-related SNPs and metabolic disease-related SNPs
Gene rs number Major
allele
Minor
allele
Common Homozygotes
(%)
Heterozygotes
(%)
Rare Homozygotes
(%)
Minor allele
frequency
HWE p
value
MTHFR rs1801133 C T 89 (81.7) 19 (17.4) 1 (0.9) 0.100 0.990
CPS1 rs1047891 C A 56 (51.9) 44 (40.7) 8 (7.4) 0.278 0.873
CUBN rs1801222 C T 78 (72.2) 29 (26.9) 1 (0.9) 0.144 0.338
CD320 rs2336573 C T 99 (90.8) 10 (9.2) 0 (0) 0.046 0.616
TCN2 rs1131603 T C 107 (98.2) 2 (1.8) 0 (0) 0.009 0.923
CLYBL rs41281112 C T 105 (96.3) 4 (3.7) 0 (0) 0.018 0.845
FUT2 rs602662 G A 60 (55.6) 30 (27.8) 18 (16.7) 0.306 0.000
TCN1 rs34324219 C A 107 (98.2) 2 (1.8) 0 (0) 0.009 0.923
FUT6 rs778805 C T 29 (26.6) 53 (48.6) 27 (24.8) 0.491 0.776
MUT rs1141321 G A 28 (25.7) 60 (55.0) 21 (19.3) 0.470 0.271
CAPN10 rs3792267 G A 79 (72.5) 24 (22.0) 6 (5.5) 0.165 0.035
CAPN10 rs2975760 T C 66 (60.6) 38 (34.9) 5 (4.6) 0.220 0.874
CAPN10 rs5030952 C T 101 (92.7) 8 (7.3) 0 (0) 0.037 0.691
KCNJ11 rs5219 C T 49 (45.0) 45 (41.3) 15 (13.8) 0.344 0.373
TCF7L2 rs12255372 G T 57 (52.3) 45 (41.3) 7 (6.4) 0.271 0.633
TCF7L2 rs7903146 C T 45 (41.3) 54 (49.5) 10 (9.2) 0.340 0.274
FTO rs9939609 T A 48 (44.0) 47 (43.1) 14 (12.8) 0.344 0.641
MCR rs17782313 T C 48 (44.0) 50 (45.9) 11 (10.1) 0.330 0.700
FTO rs8050136 C A 48 (44.0) 47 (43.1) 14 (12.8) 0.340 0.641
MC4R rs2229616 G A 99 (91.7) 9 (8.3) 0 (0) 0.042 0.651
MAF minor allele frequency, HWE Hardy-Weinberg equilibrium, χ2 chi-squared value
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the genes MTHFR, CPS1, CUBN, CD320, TCN2, CLYBL,
FUT2, TCN1, FUT6, and MUT, which have been shown to
be associated with vitamin B12 concentrations. Furthermore,
another unweighted GRS was created using allele markers
previously reported to be associated with metabolic disease
traits. The metabolic-GRS was generated from the SNPs in
the genes CAP10, KCNJ11, TCF7L2, FTO, and MC4R. A
value of 0.1 or 2 was assigned to each SNP, which denotes
the number of risk alleles on that SNP. These values were then
calculated by adding the number of risk alleles across each
SNP. The average number of risk alleles per person for the
B12-GRS was 8.69 (SD = 1.70), which ranged from 5 to 15.
The sample was stratified, by the median, into a Blow genetic
risk group,^ for those with a GRS ≤ 9 risk alleles (n = 79), and
into a Bhigh genetic risk group,^ for those with a GRS ≥ 10
risk alleles (n = 30). For the metabolic-GRS, the average num-
ber of risk alleles per person was 7.00 (SD = 2.28), which
ranged from 1 to 13. The sample was stratified, into a Blow
genetic risk group,^ for those with a GRS ≤ 8 risk alleles (n =
88), and into a Bhigh genetic risk group,^ for those with a GRS
≥ 9 risk alleles (n = 21). Linear regression was used to exam-
ine the association of the two GRS scores with the biochem-
ical and anthropometric outcomes (glucose, insulin, HbAC1,
vitamin B12, body fat %, BMI, WC, and waist-to-hip ratio
(WHR)). The interaction between the two GRS scores and
dietary factors on biochemical and anthropometric outcomes
was determined by including interaction terms (GRS × diet) in
the regression model. Models were adjusted for age, sex,
BMI, and total energy intake, wherever appropriate.
Correction for multiple testing was applied using
Bonferroni correction [adjustment p value for association
analysis was < 0.00313 [2 GRS × 8 biochemical and anthro-
pometric outcomes (Fasting blood glucose, fasting insulin,
glycated hemoglobin, vitamin B12, fat %, BMI, WC, and
WHR) = 16 test)] and for interaction < 0.00078 [2 GRS × 8
biochemical and anthropometric × 4 lifestyle factors (dietary
carbohydrate energy %, dietary protein energy %, dietary fat
energy%, and physical activity levels)) = 64]. Given that there
are no studies on GRS and no previously reported effect sizes
for the South Asians, we were unable to perform a power
calculation.
Results
Characteristics of the participants
In this study, 109 participants (mean age, 38.34 ± 6.92 years;
BMI, 24.58 ± 4.12 kg/m2) were included. Table 2 illustrates
the main characteristics of the study participants stratified ac-
cording to sex. No significant difference between men and
women was observed in the levels of fasting glucose, insulin,
HbAC1, and plasma vitamin B12 (p > 0.05).
Fig. 2 Diagram representing the study design. The diagram shows four
possible associations and four possible interactions. One-sided arrows
with unbroken lines represent genetic associations and one-sided arrows
with broken lines represent interactions between a lifestyle factor and
GRS on serum vitamin B12/metabolic traits. We tested the association
between the metabolic-GRS and vitamin B12 concentrations and meta-
bolic disease-related traits. We then tested the associations between the
B12-GRS and vitamin B12 status and metabolic disease-related traits.
Lastly, we tested whether these genetic associations were modified by
lifestyle factors (macronutrient intake and physical activity levels)
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Association between B12-GRS and obesity GRS
with biochemical and anthropometric measurements
A significant association between B12-GRS and serum vita-
min B12 was observed (p = 0.008) (Supplementary Table 1
and Fig. 3). However, this finding was not significant after
correction for multiple testing. No associations between the
B12-GRS and metabolic traits (p > 0.05) were observed
(Supplementary Table 1). Furthermore, no associations be-
tween the metabolic-GRS and vitamin B12 or metabolic traits
(p > 0.05) were observed (Supplementary Table 2).
Interaction between the B12-GRS and dietary factors
on biochemical and anthropometric measurements
An interaction was found between the B12-GRS and protein
energy (%) on log transformed WC (p = 0.002). However,
further stratification of participants based on their consump-
tion of low, medium, and high dietary protein (energy %) did
not show statistically significant associations between the
GRS and the outcome in any of the tertiles, which could ac-
count for the small sample size (Supplementary Table 3).
Table 2 Anthropometric and biochemical characteristics of men and women participants (n = 109; men 61, women 48)
Total (n = 109) Men (n = 61) Women (n = 48) p value*
Mean ± SD Mean ± SD Mean ± SD
Age (years) 38.24 ± 6.92 37.34 ± 6.97 39.38 ± 6.77 0.129
Height (cm) 164.97 ± 9.15 170.95 ± 6.18 157.36 ± 6.16 < 0.0001
Weight (kg) 67.07 ± 13.05 71.76 ± 11.81 61.11 ± 12.17 < 0.0001
BMI (kg/m2) 24.58 ± 4.12 24.51 ± 3.52 24.68 ± 4.80 0.844
Waist circumference (cm) 83.73 ± 17.97 89.83 ± 14.04 75.99 ± 19.52 < 0.0001
Hip circumference (cm) 91.16 ± 17.78 92.27 ± 13.83 89.75 ± 21.87 0.488
WHR 0.92 ± 0.11 0.98 ± 0.08 0.85 ± 0.11 < 0.0001
Fat (%) 27.25 ± 7.37 23.52 ± 5.12 32.00 ± 7.08 < 0.0001
Obesity casesa 40.37% 37.70% 43.75% 0.523
Fasting blood glucose (mg/dL) 85.64 ± 12.64 87.41 ± 15.41 83.40 ± 7.40 0.100
Fasting blood insulin (pmol/L) 68.55 ± 49.97 71.77 ± 59.12 64.46 ± 35.28 0.451
Fasting blood HbA1C (mmol/mol) 35.62 ± 5.91 35.20 ± 5.99 36.16 ± 5.84 0.402
Fasting blood B12 (pmol/L) 380.65 ± 132.83 389.80 ± 135.00 369.02 ± 130.52 0.420
Physical activity levels (low %/moderate%/high%) 72.5/19.3/8.3 70.5/19.7/9.8 75.0/18.8/6.3 0.777
Total energy (kcal/day) 2097.92 ± 456.01 2173.68 ± 427.82 2001.65 ± 476.72 0.050
Protein (energy %) 11.29 ± 2.31 11.25 ± 2.41 11.33 ± 2.20 0.853
Fat (energy %) 21.87 ± 5.31 21.64 ± 5.22 22.16 ± 5.45 0.613
Carbohydrate (energy %) 69.62 ± 8.80 69.89 ± 10.29 69.28 ± 6.52 0.721
Dietary fiber (g) 16.78 ± 8.18 17.24 ± 8.46 16.20 ± 7.85 0.513
Polyunsaturated fatty acids (g) 3.32 ± 1.69 3.36 ± 1.66 3.27 ± 1.75 0.779
Data presented as mean ± SD
BMI body mass index, SD standard deviations, WHR waist-to-hip ratio
*p < 0.05, statistically significant differences in mean values between men/women, unadjusted
bObesity cases refer to the percentage of individuals with a BMI of over 25
Fig. 3 Association between the B12-GRS and serum vitamin B12 levels.
Vitamin B12 decreasing alleles ranged from 5 to 15. Individuals with ≤ 9
or ≥ 10 alleles were grouped to obtain a reasonable number of individuals
in each group
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Interaction between the metabolic-GRS and dietary
factors on biochemical and anthropometric
measurements
We observed a significant interaction between the
metabolic-GRS and carbohydrate energy intake (%) on
waist-to-hip ratio (P interaction = 0.015) (Fig. 4 and
Table 3). Individuals who carried eight or less risk al-
leles for metabolic disease had 7.47% lower WHR mea-
surements (cm) in the highest tertile of carbohydrate
energy intake (%) (mean ± SD = 78.00 ± 7.90%) com-
pared to those with nine or more risk alleles (p =
0.035) (Table 3).
Interactions were also seen between the metabolic-GRS
and carbohydrate energy (%) on log fasting insulin con-
centrations (p = 0.011) and log WC (p = 0.031) and the
metabolic-GRS and protein energy (%) on log fasting in-
sulin levels (p = 0.032) and log WC (p = 0.011) (Table 3
and Supplementary Table 3).
Interaction between the B12-GRS and physical
activity on biochemical and anthropometric
measurements
No statistically significant interactions were observed be-
tween the two GRSs (vitamin B12 and metabolic) and
physical activity on biochemical and anthropometric mea-
surements (Table 3 and Supplementary Table 3). After
correction for multiple testing, none of these gene-diet
and gene-physical activity interactions remained statisti-
cally significant.
Discussion
To our knowledge, this is the first study to use a genetic ap-
proach to explore the relationship between metabolic traits
and vitamin B12 status in a South Asian population. Our study
confirmed the strength of the association between B12-GRS
and B12 concentrations and demonstrated the impact of genet-
ically instrumented B12 concentrations on waist circumfer-
ence, an indicator of central obesity, through the influence of
dietary protein intake. Furthermore, our study has also showed
a significant effect of metabolic-GRS on waist-to-hip ratio
through the influence of high carbohydrate intake. Given that
the total daily intake of protein is low and carbohydrate is high
in Sri Lankan adults [32], our findings, if replicated in future
studies, might carry significant public health implications in
terms of revising the food-based dietary guidelines which
could prevent central obesity and the associated CVD-
related outcomes.
In this study, we constructed a GRS consisting of ten vita-
min B12 decreasing SNPs in genes involved in vitamin B12
metabolism [17]. The B12-GRS was associated with vitamin
B12 levels, suggesting that it would be an ideal instrument for
vitamin B12 status. Given the lack of association between the
B12-GRS and metabolic disease traits in our study, we were
unable to provide evidence for linear decreases in vitamin B12
concentrations having substantive effects on metabolic dis-
ease traits. However, we found a significant interaction be-
tween the B12-GRS and protein energy (%) on log WC.
Interestingly, individuals who carried nine or less alleles had
lower WC when consuming a high protein diet compared to
those consuming a low protein diet. Although no statistically
significant differences in WC were observed between the
Fig. 4 Interaction between the
metabolic-GRS and carbohydrate
energy intake (%) on waist-to-hip
ratio (cm) (Pinteraction = 0.015).
Among those who consumed a
high carbohydrate diet, individ-
uals who carried nine or more risk
alleles had significantly higher
levels of waist-to-hip ratios com-
pared to individuals carrying
eight or less risk alleles (p =
0.035)
Int J Diabetes Dev Ctries
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alleles of the B12-GRS, the impact of the B12-GRS on WC
was observed only under the influence of a high protein diet.
Further investigations are required to confirm this finding to
determine the clinical significance and potential applications
as part of weight management interventions.
At present, carbohydrates constitute the majority of the
energy intake among South Asian countries such as Sri
Lanka (~ 71.2%) [32]; in contrast, the consumption of carbo-
hydrates is lower in Western countries (~ 45%) [33].
Furthermore, high carbohydrate intake has been associated
with an increased risk of diabetes in a South Indian population
[34] and an increase in WC among premenopausal (20–
45 years) Sri Lankan women [35]. In the present study, we
found a significant interaction between the metabolic-GRS
and carbohydrate energy percentage on waist-to-hip ratio,
where the individuals carrying more than nine risk alleles
had a higher waist-to-hip ratio among those in the highest
tertile of carbohydrate energy percentage. There are no previ-
ous reports of the risk variants used in our GRS, but Goni et al.
[36] found that carbohydrates (total and complex) interacted
with a GRS of 16 obesity/lipid metabolism polymorphisms to
modify the effect on body fat mass in 711 individuals of
Caucasian ancestry. In our study, we only observed interac-
tions of the metabolic-GRS on WC and waist-to-hip ratio,
which suggests that effects are likely to be on central obesity
as opposed to common obesity.
South Asians have a higher risk of developing obesity-
related non-communicable diseases relative to white
Caucasians despite lower BMI levels; this has been termed
the BSouth Asian phenotype.^ The distinctive features of this
phenotype include a higher WC, abdominal adiposity com-
bined with insulin resistance, and a greater predisposition to
diabetes [4]. The role of vitamin B12 in promoting this adverse
phenotype has been suggested by Yajnik et al., who demon-
strated that offspring born to mothers with a low vitamin B12
and high folate status had a greater risk of developing insulin
resistance during childhood [12]. According to Yajnik et al.,
vitamin B12 deficiency prevents the generation of tetrahydro-
folate from 5-methyltetrahydrofolate in the one-carbonmetab-
olism cycle; as a result, homocysteine levels accumulate lead-
ing to altered lean tissue deposition and reduced protein syn-
thesis [12]. Furthermore, vitamin B12 is involved in the con-
version of methylmalonyl-CoA to succinyl-CoA by the en-
zyme methylmalonyl-CoA mutase (adenosyl-B12 as a cofac-
tor). Subsequently, vitamin B12 deficiency results in elevated
methylmalonyl-CoA, inhibiting the mitochondrial enzyme
carnitine palmitoyltransferase, which may promote lipogene-
sis and insulin resistance [12, 37].
No studies to date have investigated interactions between
the two GRSs and physical activity onmetabolic traits and B12
concentrations in Asian Sri Lankans. Although 60% of Sri
Lankan adults are reported to be highly physically active
[38], no significant interactions were found between the two
GRSs and physical activity on metabolic traits, which could
be due to a small sample size andmeasurement bias associated
with self-reported physical activity questionnaire. The
strengths of our study include the use of a validated food
frequency questionnaire [18] to measure macronutrient intake,
the comprehensive measurements of lifestyle factors, and the
use of GRSs which increased the statistical power of our study
[39]. Nevertheless, some limitations need to be acknowl-
edged. The first limitation concerns the relatively small sam-
ple size of the study; however, we were still able to identify
significant gene-diet interactions. Furthermore, we used
Bonferroni correction to correct for multiple testing and this
can often lead to larger power, specifically where studies have
a small sample size and a small number of disease-associated
markers. This is also true for when studies have a large allele
frequency difference due to a small sample size [40].
Secondly, information about the type of oil used for frying,
the estimation of different dietary fat components (monoun-
saturated or saturated fatty acids), and vitamin B12 intake was
not collected. This could have limited our in-depth analysis of
interactions of specific macronutrients and vitamins with the
two GRSs. Furthermore, the study was limited to Sinhalese
adults in Colombo, and the conclusions may not be applicable
to other ethnic groups in Sri Lanka. Finally, none of the ge-
netic associations or gene-lifestyle interactions were statisti-
cally significant after correction for multiple testing; however,
given that this is the first study using a genetic approach to
establish a relationship between vitamin B12 status and meta-
bolic disease outcomes in South Asians, we have taken into
consideration the significant findings; hence, further large
studies are required to replicate our findings.
In summary, our study suggests that a genetically lowered
vitamin B12 concentration may have an impact on central
obesity in the presence of a dietary influence; however, our
study failed to show an impact of the metabolic-GRS on low-
ering B12 concentrations through a dietary influence. Our
study also showed a significant effect of the metabolic-GRS
on waist-to-hip ratio, another indicator of central obesity,
through the influence of a high carbohydrate intake.
However, after correction for multiple testing, none of these
findings were statistically significant. Hence, further replica-
tion studies are highly warranted on large samples to confirm
or refute our findings.
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